1. Introduction {#sec1}
===============

Treatments\' diversity is a feature of Traditional Chinese medicine. Traditional Chinese medicine includes decoctions, acupuncture, moxibustion, and massage. More than one of the above were used at the same time, which can be defined as complex interventions. What complex interventions means? In 2000, the British Medical Research Council (MRC) had proposed the following definition: "complex interventions are built up from a number of components, which may act both independently and interdependently. The components usually include behaviors, parameters of behaviors (e.g., frequency, timing), and methods of organizing and delivering those behaviors (e.g., type(s) of practitioner, setting and location)" \[[@B1]\].

Therefore, only to improve the implementation and evaluation of complex interventions can make TCM more scientific and easier to grasp. Traditional Chinese medicine and western medicine have to face the common problem. The complex interventions have been concerned in the world; several scholars have put forward some models for complex interventions\' trials; the most common models are van Meijel et al. model, Bradley et al. Model \[[@B2]\], and the framework for the development and evaluation of complex interventions published by MRC. But the method for complex interventions\' researches is still very short; only Ralph Möhler et al. \[[@B3]\] proposed criteria for reporting the development and evaluation of complex interventions in healthcare.

In order to realize the methodological problems of complex interventions\' researches in TCM, we assessed the quality of complex interventions\' articles published in Chinese Journal Integrated Traditional and Western Medicine, Journal of Traditional Chinese Medicine from 2007 to 2012, 12 volumes 168 issues in total. Based on the framework by MRC, an evaluation of these complex interventions\' articles was made by using the proposed standards special for evaluating the complex interventions. In addition, we also used CONSORT FOR TCM \[[@B4]\] criteria, which are applicable to evaluating RCTs of TCM proposed by Chinese Cochrane Center, to evaluate general things of these articles. Our assessment intends to find out the problems of complex interventions\' trials and inadequacies in article writing, so that we can give some suggestions to latecomers.

2. Methods {#sec2}
==========

2.1. The Sources of Material {#sec2.1}
----------------------------

We selected complex interventions\' articles published in Chinese Journal Integrated Traditional and Western Medicine, Journal of Traditional Chinese Medicine in 2007--2012 by hand.  Inclusion criteria: (1) a complex intervention as defined by MRC \[[@B1]\], (2) clinical trials. Exclusion criteria: (1) without control interventions, (2) articles belong to case reports or short reports.

2.2. Methods and Content {#sec2.2}
------------------------

### 2.2.1. Methods {#sec2.2.1}

Two trained evaluators independently evaluated all articles based on the criteria, checked jointly, and then resolved disagreements by consensus.

### 2.2.2. Evaluation of Complex Intervention Articles {#sec2.2.2}

The general things of articles (see Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}).The proposed topics for reporting the complex interventions (see [Table 3](#tab3){ref-type="table"}).The CONSORT FOR TCM criteria (see [Table 4](#tab4){ref-type="table"}).

### 2.2.3. Statistical Methods {#sec2.2.3}

No formal statistical tests were used; all data is presented as counts with percentages.

3. Results {#sec3}
==========

In 2007−2012, Chinese Journal Integrated Traditional and Western Medicine and Journal of Traditional Chinese Medicine have published 801, 540 clinical trials\' articles, respectively, 244, 143 of them belong to complex interventions. Finally, 354 articles found and most studies on gynecology and reproductive system diseases (13%), followed by bone and joint or motion sickness, Tumor, digestive diseases, endocrine diseases. 89.3% of the trials only have one participating center, only 118 (33.3%) trails funded by national, provincial, ministry, or municipal funding for the data in detail, see Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}.

Details on the evaluation based on the purposed content are presented in [Table 3](#tab3){ref-type="table"} and evaluation based on the CONSORT FOR TCM is in [Table 4](#tab4){ref-type="table"}.

4. Discussion {#sec4}
=============

According to the result of our assessment, we can realize the current situation and shortages of complex interventions in TCM as follows.

4.1. The Proposed Content Special for Complex Interventions Trials {#sec4.1}
------------------------------------------------------------------

### 4.1.1. The Introduction of Background Which Leads to the Complex Interventions {#sec4.1.1}

The complex interventions are widely used, but are not meant for abuse of them, Professor Jialiang Wang thinks the clinical application of complex interventions requires certain conditions. It is usually applied to serious chronic diseases or epidemic diseases which still cannot be well treated. All these diseases were complicated and cannot be treated with a single measure \[[@B5]\]. So we think researchers should make a reasonable explanation of the target disease, including the shortcomings of current treatment methods and the disadvantages of single components which can support us to use complex interventions. The evaluation showed that many articles deficient in this information, even not mentioned.

### 4.1.2. The Type of Trial\'s Objective {#sec4.1.2}

According to research methods and designs, all studies can be divided into two major types, namely, exploratory studies and confirmatory studies. The latter has a more strong ability of confirmation than the former to evaluate the therapeutic efficiency \[[@B6]\].

Most included articles intended to observe the clinical efficacy of the treatments, so they cannot provide solid evidences. What is more, a lot of researchers have not clearly described what the effects should have. Only a small part of articles belong to confirmatory studies.

### 4.1.3. Selection of the Intervention\'s Components {#sec4.1.3}

Complex interventions are combinations of several components. How to select components for complex interventions is a primary problem to solve. Following the framework by MRC, the first step is identifying existing evidence \[[@B7]\]. Evidence for complex interventions may come from systematic reviews, animal studies, clinical researches, or accumulation of personal clinical experiences. Making all interventions based on best evidence is not always realistic clinical medicine will be more practical \[[@B5]\], so plenty of effective interventions; get from accumulations of experience and deepening researches. At least, the selection of components cannot be fabricated.

As results of the evaluation presented, researchers have not paid attention to select components scientifically many articles; are without mention. Evidence selection was given by few articles, which mostly came from animal studies or clinical researches. In addition, the studies on Chinese medicine decoctions are still in the stage of taking apart prescriptions, that is, study on herbs, respectively, rather than regarding them as a whole.

### 4.1.4. Rationale for Theoretical Basis of Combining the Complex Interventions\' Program {#sec4.1.4}

The interactions between different components are complex, which will make a difference in complex interventions\' efficacy. Therefore, we think that designing a complex intervention also should be based on strong evidence. Wherever possible, evidence should be combined from different sources that do not share the same weaknesses \[[@B8]\]. The evaluation revealed that most complex interventions\' trials lack sufficient and scientific evidence; that is to say, what theories support us to combine this rather than those components is not clear. Researchers should develop the complex interventions\' program following the evidence-based science.

### 4.1.5. The Type of Complex Interventions\' Designs {#sec4.1.5}

As the efficacious method to prevent selection biases, randomization is always the first to be considered. 88.1% of these articles claimed that their trials were randomized controlled trials, but not all of them have stated the method of random generation. Whether randomizations were true or not cannot be speculated.

Although RCT is good, it also has some limitations in the process of implementation. RCT should based on reasonable hypothesis and good generalizability, which can make it more valuable \[[@B9]\]. Sometimes, randomization may be unnecessary and other designs preferable \[[@B7], [@B10]\]. More and more practical randomized controlled trials (PRCTs) were applied to clinical complex interventions trials, no longer limited in explanatory randomized controlled trial (ERCT) \[[@B11]\]. The new guidelines released by MRC in 2008 provided several designs for complex interventions evaluation, which including individually randomized trials, cluster randomized trials, stepped wedge designs, preference trials, and randomized consent designs, N of 1 designs \[[@B7]\]. Researchers should choose a more appropriate one instead of using ERCT all the time.

### 4.1.6. The Combination Type of Intervention\'s Components and Pilot Study {#sec4.1.6}

The combinations of complex interventions in these articles involved various formations. In order to know the form of combinations, we classified them roughly. "Chinese medicine" included decoctions and Chinese patent drugs; "Western medicine" included western medicines and conventional or basic therapies; "nondrug treatments" included acupuncture and moxibustion, massage, radiotherapy, surgery, therapeutic equipments (such as laser, and ultrasound), and gymnastics. Trials which combined Traditional Chinese medicine and Western Medicine were more common in the articles reviewed. Evaluations are often undermined by problems of acceptability, compliance, delivery of the intervention, recruitment and retention, and smaller than expected effect sizes that could have been predicted by thorough piloting \[[@B7], [@B12]\]. But none of the included articles has pilot study.

### 4.1.7. Control Interventions and Evaluating Outcomes {#sec4.1.7}

Positive drugs are more often selected as control interventions. Placebo controls were not common, which may be caused by potential ethical issues.

The results of complex interventions\' trials would be more various than single intervention. Using different kinds of methods to evaluate the results will be more objective and comprehensive. It is important also to consider which sources of variation in outcomes matter and to plan appropriate subgroup analyses \[[@B7]\].

### 4.1.8. Categorizing Interactions between Different Components {#sec4.1.8}

Elaboration of interactions between components is very short in included articles. Three kinds of interactions may make the efficacy better: some similar components combined for enhancing the overall efficacy; components complemented each other; one component reduced the side effects of another. But none of the articles claimed conclusion that efficiency was reduced by using the complex interventions; it means all the researchers considered that complex interventions were better than a single intervention. Most complex interventions are still in the stage of observing the clinical efficacy, and studies of interactions between components are very short; it is essential to do further confirmatory studies in future, which will also become a focus of medicine researches in future.

### 4.1.9. The Advantages of Using Complex Interventions {#sec4.1.9}

Although vast majority of researchers have claimed that their complex interventions were better than single intervention, most of them only mentioned "better efficacy" lightly, no specific and detailed explanation of the advantages. Furthermore, plenty of articles limited to the comparison of clinical efficacy between different interventions and ignored the comparisons of convenience and economics\' aspect which would make the evaluation more comprehensive.

4.2. Overview of General Things and Evaluation Results Based on CONSORT FOR TCM {#sec4.2}
-------------------------------------------------------------------------------

Besides the evaluation special for complex interventions, we have assessed these articles based on CONSORT FOR TCM criteria. Then we compared our result to an earlier similar study which evaluated RCTs published on Chinese Journal Integrated Traditional and Western Medicine in 1999--2004.

The results of our evaluation presented that few researchers used the diagnostic criteria and syndromes of TCM (42.7%). So we can speculate that some researches only connected one disease with certain medicine(s) without using syndrome differentiation of TCM.

About selecting outcome measures, intermediate indicators were more common than endpoint which may be due to its shorter time for observation. The fact that less use of syndrome indicators (24.9%) revealed that many trials are still in the stage of "diseases without syndrome." The indicators except relating to efficacy, such as economic indicators, were rarely used.

The most significant problem of giving interventions\' details is the unclear description of the quality control of Chinese medicine decoctions, including the metropolis, batch number, and concocting method, which has greatly increased the biases of Chinese medicine in the process of using and the boiling. In order to solve the problem, some researches use granules of Chinese medicines instead of herb pieces to reduce the biases. But Weixiong Liang thinks that Chinese medicine granules also have two major shortages. Firstly, they only have production standards of Chinese medicine granules without national standards of quality control. Secondly, in the process of boiling, herb pieces would interact with each other, but granules lack the link \[[@B13]\]. The two points above will be the main bottleneck of Chinese medicine granules.

Although most articles have explained the results, not all of them explained both on statistics and clinical areas. Deficiency of the explanation based on TCM theory is a common issue of the clinical trials which selected Chinese patent drugs or nondrugs as the interventions. Furthermore, there are several problems with complex interventions\' trials just as general RCTs, including quality control, and informed consent and ethical approval. A great number of articles have not listed the deficiencies or potential biases of their trials and have not mentioned the acknowledgments or conflicts.

Comparing our results with a similar assessment made by Mao et al. who used Consort statement to evaluate RCTs published in the Chinese Journal of Integrated Traditional and Western medicine in 1999--2004 \[[@B14]\], some large improvements have been presented: the reporting of exclusion criteria increased from 28.42% to 71.8%, statistical methods (77.95% to 98%), statistic in detail (33.3% to 91.2%), adverse events (34.71% to 55.9%), informed consent (0.24% to 38.7%), follow-up records (11.42% to 29.1%), and syndromes differentiation of TCM (12.66% to 42.7%). The sample size determination, blinding, ethical approval, flow chart, and analysis of potential biases all improved very little. Therefore, the quality of RCTs still has a large room for improvement.

Zhan et al. have evaluated the RCTs published on several Chinese medicine journals from 1976 to 1996 \[[@B15]\], however, their evaluation presented that non-single intervention trails only accounted for 19%. These years, the quantity of nonsingle intervention trials has increased, which accounted for 1/3 each year more or less. But the publication biases still exist; 352 included articles stated positive results, which may lead readers to draw some wrong conclusions about treatment efficacies.

Compared to the results of a similar foreign assessment, we can see that there were large gaps between them. Mills et al. investigated 253 articles published in the BMJ, JAMA, Lancet Archives, and Annals about the quality of randomization \[[@B16]\]. The results showed that sequence generation is 80.2%, allocation concealment is 48.2%, description of the blinding method is 81.4%, and sample size is 82.6%. Flow charts were also more common. All of the above were better than RCTs in TCM.

5. Summary {#sec5}
==========

As the results of our quality assessment showed, complex interventions articles in TCM need to be improved urgently. The descriptions of theories or primary researches supporting the complex interventions are insufficient and unreliable; great majority of researchers designed their complex interventions depending on experiences. Explanations of interactions between different components were inadequate; the researchers have not explained the relationships between them. All these are important points to a complex interventions\' trial. Most interventions of included articles mixed with western medicines, Chinese patent drugs, injection therapies, and so forth, which perhaps reduced the proportions in some items of TCM.

Also our evaluation has some shortages; the proposed criteria for complex interventions are immature, perhaps some key contents are missing.

With the development of evidence-based medicine in recent years, some aspects of RCTs are already better than before. As more and more people pay attention to the evaluation of complex interventions, we are convinced that someone will propose a better criteria for evaluating the complex interventions in the near future, and the complex interventions trials will be improved.

This work was supported by Special Research Project of TCM by State (no. 201107006, no. 201207005), Technology Platform Construction of Clinical Study on Traditional Chinese Medicine, Science and Technology Project of Beijing (Z111102070311001). Songfeng Zhang helped to complete the quality assessment; Professor Deying Kang, Professor Xiantao Li, Lijie Jiang, others gave some valuable suggestions for modifies. The authors acknowledge these contributions.

###### 

Data sources.

                                                                   2007         2008         2009         2010         2011         2012
  ---------------------------------------------------------------- ------------ ------------ ------------ ------------ ------------ ------------
  Chinese Journal Integrated Traditional and Western Medicine                                                                       
  Clinical trials\' article                                        181          146          131          99           101          143
  The complex interventions\' articles belong to clinical trials   78 (43.1%)   44 (30.1%)   39 (29.8%)   24 (24.2%)   31 (30.7%)   28 (19.6%)
                                                                                                                                    
  Journal of Traditional Chinese Medicine                                                                                           
  Clinical trials\' article                                        63           68           58           60           155          136
  The complex interventions\' articles belong to clinical trials   19 (30.2%)   15 (22.1%)   14 (24.1%)   19 (31.7%)   28 (18.1%)   48 (35.3%)

###### 

The data of included articles in general.

  Item                                                       Sub-item                                          Number of reported (%)
  ---------------------------------------------------------- ------------------------------------------------- ------------------------
  The top five types of diseases that articles involve are   Gynecology and reproductive system diseases       46 (13.0%)
  Bone and joint or motion sickness                          41 (11.6%)                                        
  Tumor                                                      39 (11.0%)                                        
  Digestive diseases                                         37 (10.4%)                                        
  Endocrine diseases                                         32 (9.0%)                                         
                                                                                                               
  Funding                                                    National                                          41 (11.6%)
  Provincial, ministry, or municipal                         77 (21.8%)                                        
  Others                                                     10 (2.8%)                                         
  No explanations                                            226 (63.8%)                                       
                                                                                                               
  The department of first author                             Colleges, universities, and affiliated hospital   188 (53.1%)
  Other hospitals at all levels                              139 (39.3%)                                       
  Research institutions                                      27 (7.6%)                                         
                                                                                                               
  The number of participating centers                        1                                                 316 (89.3%)
  2--5                                                       32 (9.0%)                                         
  6+                                                         6 (1.7%)                                          
                                                                                                               
  Other information                                          Informed Consent                                  137 (38.7%)
  Ethical approval                                           9 (2.5%)                                          
  Acknowledgments                                            3 (0.8%)                                          

###### 

The results of using the proposed criteria for evaluation.

  Item                                                                       No.           Subitem                                                  Number (%)
  -------------------------------------------------------------------------- ------------- -------------------------------------------------------- -------------
  The introduction of background which lead to the complex interventions     1             Introduction of target disease                           214 (60.5%)
  Limitations of using single interventions                                  145 (41.0%)                                                            
  Not mentioned                                                              93 (26.3%)                                                             
                                                                                                                                                    
  The type of objectives                                                     2             Main purpose of observing clinical efficacy              324 (91.5%)
  Demonstrate results of former research(es)                                 30 (8.5%)                                                              
                                                                                                                                                    
  Rationale for the selection of the intervention\'s components              3             Depend on systematic review results of clinical trials   1 (0.3%)
  Based on former clinical trials                                            99 (28.0%)                                                             
  The results of animal studies                                              112 (31.6%)                                                            
  Experts consensus                                                          5 (1.4%)                                                               
  Personal clinical experiences                                              29 (8.2%)                                                              
  Not mentioned                                                              108 (30.5%)                                                            
                                                                                                                                                    
  Description the theoretical basis of complex interventions\' program       4             Depend on systematic review results of clinical trials   0 (0.0%)
  Based on former clinical trials                                            25 (7.1%)                                                              
  The results of animal studies                                              0 (0.0%)                                                               
  Experts consensus                                                          1 (0.3%)                                                               
  Personal clinical experiences                                              11 (3.1%)                                                              
  Not mentioned                                                              317 (89.5%)                                                            
                                                                                                                                                    
  Pilot study                                                                5             Is there pilot study or not?                             0 (0.0%)
                                                                                                                                                    
  Sample size                                                                6             \<50                                                     32 (9.0%)
  50--99                                                                     193 (54.5%)                                                            
  100--299                                                                   118 (33.3%)                                                            
  ≥300                                                                       11 (3.1%)                                                              
                                                                                                                                                    
  The type of design                                                         7             Randomized controlled trials                             312 (88.1%)
   (i) Randomization                                                         225 (63.6%)                                                            
   (ii) Quasi-randomization                                                  49 (13.8%)                                                             
   (iii) Randomized, no method stated                                        38 (10.7%)                                                             
  Cohort study                                                               8 (2.3%)                                                               
  Crossover design                                                           1 (0.3%)                                                               
  Case-control study                                                         1 (0.3%)                                                               
  Non-randomized concurrent controlled trials                                32 (9.0%)                                                              
                                                                                                                                                    
  The categories of combinations between intervention\'s components          8             Chinese medicine alone                                   113 (31.9%)
   (i) Chinese medicines with different formulations                         22 (6.2%)                                                              
   (ii) Chinese medicines + non-drug                                         67 (18.9%)                                                             
   (iii) Difference kinds of non-drug TCM                                    24 (6.8%)                                                              
  Western medicine alone                                                     0 (0.0%)                                                               
  Chinese plus western medicine                                              241 (68.1%)                                                            
   (i) Chinese medicines + western medicines/basic treatments                207 (58.5%)                                                            
   (ii) Western medicines + non-drug                                         20 (5.6%)                                                              
   (iii) Chinese medicines + western medicines + non-drug                    14 (4.0%)                                                              
                                                                                                                                                    
  Control interventions                                                      9             A single component as effective control                  156 (44.1%)
  Several components combined as a effective control                         185 (52.3%)                                                            
  Placebo control                                                            12 (3.4%)                                                              
  Blank control                                                              1 (0.3%)                                                               
                                                                                                                                                    
  Indicators for evaluating the outcomes                                     10            One indicator                                            116 (32.8%)
  Multiple indicators for comprehensive evaluation                           238 (67.2%)                                                            
                                                                                                                                                    
  Elaborating interactions between different components                      11            Interactions lead to better efficacy                     118 (33.3%)
   (i) Some similar components combined for enhancing the overall efficacy   60 (16.9%)                                                             
   (ii) Components complemented each other to enhance the efficacy           27 (7.6%)                                                              
   (iii) Improved by reducing side effects                                   31 (8.8%)                                                              
  Interactions lead to worse efficacy                                        0 (0.0%)                                                               
   (i) Efficacy reduced without side effect                                  0 (0.0%)                                                               
   (ii) Some side effects generated                                          0 (0.0%)                                                               
  Not mentioned                                                              236 (66.7%)                                                            
                                                                                                                                                    
  The advantages of using complex interventions\' program                    12            More effective                                           297 (83.9%)
  Shorten the treatment time                                                 24 (7.6%)                                                              
  Fewer side effects (security)                                              96 (27.1%)                                                             
  Easier to implement                                                        19 (5.4%)                                                              
  Less cost of treatment                                                     18 (5.1%)                                                              
  Not mentioned                                                              36 (10.2%)                                                             

###### 

The results of assessment based on CONSORT FOR TCM.

  Paper section and topic                                   Item          Description                                                                                                                                Number (%)
  --------------------------------------------------------- ------------- ------------------------------------------------------------------------------------------------------------------------------------------ -------------
  Title and abstract                                        1             Is there abstract or not?                                                                                                                  269 (76.0%)
  Introduction                                                                                                                                                                                                        
   Background                                               2             A brief statement of reasons for trials and medicines                                                                                      261 (73.7%)
   Objectives                                               3             Specific objectives or hypotheses                                                                                                          237 (66.9%)
  Methods                                                                                                                                                                                                             
   Participants                                             4             Diagnostic criteria of Western medicine                                                                                                    299 (84.5%)
  Using the diagnostic criteria and Syndromes of TCM        151 (42.7%)                                                                                                                                              
  Inclusion criteria                                        268 (75.7%)                                                                                                                                              
  Exclusion criteria                                        254 (71.8%)                                                                                                                                              
  The settings and location where the data collected        301 (85.0%)                                                                                                                                              
   Interventions                                            5             Details on interventions of each group (such as dosage, metropolis, concocting method, and batch number)                                   161 (45.5%)
  Strategy of quality control                               5 (1.4%)                                                                                                                                                 
   Outcomes                                                 6             Clearly defined outcome measures and when applicable                                                                                       256 (72.3%)
  Using the syndrome indicators to evaluate the outcome     88 (24.9%)                                                                                                                                               
   Sample size                                              7             How sample size was determined                                                                                                             4 (1.1%)
   Randomization                                                                                                                                                                                                      
    (i) Sequence generation                                 8             Method used to generate the random allocation sequence                                                                                     260 (73.4%)
    (ii) Allocation concealment                             9             Method used to implement the random allocation sequence                                                                                    29 (8.2%)
    (iii) Implementation                                    10            Who generated the allocation sequence, who enrolled participants, and who assigned participants to their groups?                           12 (3.4%)
    (iv) Blinding                                           11            Single blinding                                                                                                                            8 (2.3%)
  Double blinding                                           13 (3.7%)                                                                                                                                                
  Not mentioned                                             333 (94.1%)                                                                                                                                              
  Statistical methods                                       12            Description of statistical methods                                                                                                         347 (98.0%)
  Results                                                                                                                                                                                                             
   Participant flow                                         13            Flow of participants\' changes in each stage                                                                                               90 (25.4%)
  A diagram of flow                                         0 (0.0%)                                                                                                                                                 
  Compliance                                                15 (4.2%)                                                                                                                                                
   Recruitment                                              14            The method for collection                                                                                                                  6 (1.7%)
  Follow-up record                                          103 (29.1%)                                                                                                                                              
   Baseline data                                            15            Baseline demographic and clinical characteristics of each group                                                                            68 (19.2%)
   Numbers analyzed                                         16            Whether the analysis was by ''intention-to-treat"                                                                                          7 (2.0%)
   Outcomes and estimation                                  17            Positive results                                                                                                                           352 (99.4%)
  Negative results                                          0 (0.0%)                                                                                                                                                 
  Equivalent results                                        2 (0.6%)                                                                                                                                                 
  The precise of data                                       323 (91.2%)                                                                                                                                              
  Give the confidence interval and value of "*P*"           40 (11.3%)                                                                                                                                               
   Ancillary analyses                                       18            Results of any other analyses performed, including Subgroup analyses and adjusted analyses, distinguishing prespecified from exploratory   5 (1.4%)
   Harms                                                    19            All important harms or unintended effects in each group                                                                                    198 (55.9%)
  Discussion                                                                                                                                                                                                          
   Interpretation                                           20            Interpretation of the results                                                                                                              353 (99.7%)
  Explaining the significance in statistics and treatment   255 (72.0%)                                                                                                                                              
  Explain the results with theories of TCM                  218 (61.6%)                                                                                                                                              
  Potential bias                                            28 (7.9%)                                                                                                                                                
   Generalizability                                         21            Generalizability (external validity) of the results                                                                                        86 (24.3%)
   Overall evidence                                         22            Description of the interest conflict between researchers and participants                                                                  0 (0.0%)

Note: items in Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"} are calculated one by one; few items may cross with each other, so we counted them more than one.

[^1]: Academic Editor: Allan Hackshaw
